NFJ Investment Group LLC acquired a new stake in UiPath, Inc. (NYSE:PATH – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 508,943 shares of the company’s stock, valued at approximately $8,342,000. NFJ Investment Group LLC owned 0.10% of UiPath as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also modified their holdings of the business. Arrowstreet Capital Limited Partnership grew its position in shares of UiPath by 9.8% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,340,840 shares of the company’s stock valued at $54,756,000 after purchasing an additional 298,853 shares during the period. Atlas Capital Advisors Inc. acquired a new position in UiPath during the 4th quarter worth approximately $37,000. Kestra Advisory Services LLC acquired a new position in UiPath during the 4th quarter worth approximately $238,000. The Manufacturers Life Insurance Company boosted its position in UiPath by 247.5% during the 4th quarter. The Manufacturers Life Insurance Company now owns 320,679 shares of the company’s stock worth $5,260,000 after acquiring an additional 228,398 shares during the last quarter. Finally, CANADA LIFE ASSURANCE Co boosted its position in UiPath by 2.8% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 2,107,481 shares of the company’s stock worth $34,500,000 after acquiring an additional 56,711 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.
UiPath Stock Performance
Shares of NYSE PATH opened at $10.54 on Friday. UiPath, Inc. has a 52 week low of $9.20 and a 52 week high of $19.84. The stock has a market capitalization of $5.46 billion, a P/E ratio of 17.56, a PEG ratio of 1.34 and a beta of 0.96. The stock’s fifty day moving average is $10.74 and its 200 day moving average is $12.74.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on PATH shares. Weiss Ratings reissued a “hold (c)” rating on shares of UiPath in a report on Friday, March 27th. UBS Group cut their price target on UiPath from $17.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, March 12th. Canaccord Genuity Group cut their price target on UiPath from $19.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, March 12th. Morgan Stanley cut their price target on UiPath from $17.00 to $15.00 and set an “equal weight” rating for the company in a report on Friday, May 29th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $15.00 price target on shares of UiPath in a report on Friday, May 29th. Two equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, UiPath currently has a consensus rating of “Hold” and a consensus price target of $13.87.
Get Our Latest Stock Analysis on PATH
UiPath Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Further Reading
- Five stocks we like better than UiPath
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
